Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic and epigenetic heterogeneity and the impact on cancer relapse
Ciaran Hassan, Ebrahim Afshinnekoo, Sheng Li, et al.
Experimental Hematology (2017) Vol. 54, pp. 26-30
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
Zeda Zhang, Chuanli Zhou, Xiaoling Li, et al.
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 584-598.e11
Open Access | Times Cited: 135
The Impact of Heterogeneity on Single-Cell Sequencing
Samantha L. Goldman, Matthew MacKay, Ebrahim Afshinnekoo, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 112
New strategies to treat AML: novel insights into AML survival pathways and combination therapies
Ramya Nair, Alejandro Salinas-Illarena, Hanna‐Mari Baldauf
Leukemia (2020) Vol. 35, Iss. 2, pp. 299-311
Closed Access | Times Cited: 72
Convergent epigenetic evolution drives relapse in acute myeloid leukemia
Kevin A. Nuno, Armon Azizi, Thomas Koehnke, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 13
Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
Samantha L. Goldman, Ciaran Hassan, Mihir Khunte, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 73
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
Aleksandr Ianevski, Jenni Lahtela, Komal Kumar Javarappa, et al.
Science Advances (2021) Vol. 7, Iss. 8
Open Access | Times Cited: 41
Identifying acute myeloid leukemia subtypes based on pathway enrichment
Ling Zhong, Jiangti Luo, Junze Dong, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Hypoxia‐inducible transgelin 2 selects epithelial‐to‐mesenchymal transition and γ‐radiation‐resistant subtypes by focal adhesion kinase‐associated insulin‐like growth factor 1 receptor activation in non‐small‐cell lung cancer cells
In‐Gyu Kim, J H Lee, Seo‐Yeon Kim, et al.
Cancer Science (2018) Vol. 109, Iss. 11, pp. 3519-3531
Open Access | Times Cited: 29
Doxorubicin selectively induces apoptosis through the inhibition of a novel isoform of Bcl‑2 in acute myeloid leukaemia MOLM‑13 cells with reduced Beclin 1 expression
Milan Vu, Nick Kassouf, Rosemary Ofili, et al.
International Journal of Oncology (2020) Vol. 57, Iss. 1, pp. 113-121
Open Access | Times Cited: 18
Decelerated DNA methylation age predicts poor prognosis of breast cancer
Junting Ren, Meixia Wang, Yi Su, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 18
ImmunoPET, [64Cu]Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft Model
Srideshikan Sargur Madabushi, Jamison Brooks, Darren Zuro, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 24, pp. 7463-7474
Open Access | Times Cited: 17
Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway
Dongxin Hu, Qifeng Sun, Lin Xu, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 4, pp. 464-478
Open Access | Times Cited: 10
The molecular signature of AML with increased ALDH activity suggests a stem cell origin
Rachel Blume, Eugen Rempel, Linda Manta, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2018) Vol. 59, Iss. 9, pp. 2201-2210
Closed Access | Times Cited: 16
Resistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies
Jianbiao Zhou, Wee Joo Chng
World Journal of Clinical Oncology (2018) Vol. 9, Iss. 5, pp. 90-97
Open Access | Times Cited: 16
Enzymatic nucleosome acetylation selectively affects activity of histone methyltransferases in vitro
Viacheslav V. Trush, Christian Feller, Alice Shi Ming Li, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2022) Vol. 1865, Iss. 5, pp. 194845-194845
Closed Access | Times Cited: 9
Single‐Cell Sequencing in Normal and Malignant Hematopoiesis
Nicola K. Wilson, Berthold Göttgens
HemaSphere (2018) Vol. 2, Iss. 2
Open Access | Times Cited: 14
Challenges in promoter methylation analysis in the new era of translational oncology: a focus on liquid biopsy
Catia Mio, Giuseppe Damante
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 6, pp. 166390-166390
Open Access | Times Cited: 7
NADH dehydrogenase subunit 1/4/5 promotes survival of acute myeloid leukemia by mediating specific oxidative phosphorylation
Ye Kuang, Chuanmei Peng, Yulin Dong, et al.
Molecular Medicine Reports (2022) Vol. 25, Iss. 6
Open Access | Times Cited: 7
Single-cell transcriptome analysis upon ECM-remodeling meningioma cells
Wenqiang Che, Yujiao Wang, Yang Liu, et al.
Neurosurgical Review (2024) Vol. 47, Iss. 1
Closed Access | Times Cited: 1
The Emerging Roles of Aldehyde Dehydrogenase in Acute Myeloid Leukemia and Its Therapeutic Potential
Hossein Ayatollahi, Atefe Rahmati, Sajad Goudarzi, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 3, pp. 246-255
Closed Access | Times Cited: 6
An Updated Overview of the Role of CYP450 during Xenobiotic Metabolization in Regulating the Acute Myeloid Leukemia Microenvironment
Cristian Sandoval, Yolanda Calle, Karina Godoy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6031-6031
Open Access | Times Cited: 3
Genetic features and efficacy of decitabine-based chemotherapy in elderly patients with acute myeloid leukemia
Bianhong Wang, Wei Guan, Na Lv, et al.
Hematology (2021) Vol. 26, Iss. 1, pp. 371-379
Open Access | Times Cited: 6
DDX51 gene promotes proliferation by activating Wnt/β-catenin signaling in breast cancer.
Weibo Sun, Shundong Cang, Xiaodong Lv, et al.
PubMed (2017) Vol. 10, Iss. 11, pp. 10892-10900
Closed Access | Times Cited: 5
Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia
Kevin A. Nuno, Armon Azizi, Thomas Köhnke, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
The inhibitory effects of cisplatin‑radiation combination treatment on malignant osteosarcoma MG‑63 cells and BRCA1‑p53 pathways are more efficient than single treatments
Hongbin Sun, He‐Yuan Wang, Bing Wu, et al.
Oncology Letters (2019)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top